OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
SLDX
STELLA DIAGNOSTICS INC.
Common Stock
0.049
0.00
0.00%
0.041 / 0.0629 (1 x 1)
Real-Time Best Bid & Ask: 05:00pm 06/12/2025
Delayed (15 Min) Trade Data: 12:00am 04/04/2025
0.00
N/A
0
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For SLDXFind Out More
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 04/04/2025 | 15:18:41 | 0.049 | 0.01 | 100 |
| 03/28/2025 | 15:52:23 | 0.04 | -0.00 | 240 |
| 03/25/2025 | 09:31:56 | 0.0431 | 0.00 | 10,000 |
| 03/05/2025 | 14:15:23 | 0.0431 | 0.00 | 100 |
| 02/20/2025 | 10:35:07 | 0.0431 | -0.02 | 500 |
News
Filings and Disclosure
Company Description
Stella Diagnostics, Inc. through one of its subsidiaries, World Reach Pharma, LLC will harness the power of biotechnology, innovation, and science to deliver high-quality CGMP pharmaceutical products to patients and healthcare providers. As an innovative 503B Outsourcing Facility, we will be a premier provider of superior compounded medications that protect, improve, and enhance patients' lives - all at affordable prices. Obtaining a 503B designation will allow us to produce sterile and non-sterile medications in bulk under strict FDA oversight, ensuring the highest safety and quality standards. WRP will special in addressing drug shortages, customizing formulations to meet specific healthcare needs, and delivering scalable solutions for healthcare facilities. By leveraging advanced manufacturing technologies and streamlined processes, WRP will develop a customized product portfolio with vastly reduced development times and costs. This will enables us to quickly respond to market demands and provide tailored solutions that will empower healthcare providers to deliver exceptional care.
Videos
This company has not added any videos
Pink Current Information
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Company’s board of directors includes at least two Independent Directors.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
51.00
Change
0.28 (0.55%)
Bid
51.00
Ask
51.10
Volume
3586
Time
00:00
